VelivetTriphasic Regimen (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Velivet drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Desogestrel and Ethinyl Estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-03-01 |
END MARKETING DATE: | 0000-00-00 |
Velivet Triphasic Regimen HUMAN PRESCRIPTION DRUG Details:
Item Description | Velivet Triphasic Regimen from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2004-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0555-9051_79855437-35e7-459e-8f48-ce03f60102ae |
PRODUCT NDC: | 0555-9051 |
APPLICATION NUMBER: | ANDA076455 |